Wasatch Advisors LP Boosts Stock Position in HealthEquity, Inc. $HQY

Wasatch Advisors LP raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 10.5% in the 2nd quarter, HoldingsChannel reports. The firm owned 7,960,735 shares of the company’s stock after buying an additional 757,801 shares during the period. HealthEquity makes up approximately 4.7% of Wasatch Advisors LP’s holdings, making the stock its largest holding. Wasatch Advisors LP owned approximately 0.10% of HealthEquity worth $719,014,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC raised its position in shares of HealthEquity by 4.2% in the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after purchasing an additional 116 shares during the period. Truist Financial Corp boosted its holdings in shares of HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after buying an additional 119 shares during the period. Fiduciary Trust Co boosted its holdings in shares of HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after buying an additional 120 shares during the period. Larson Financial Group LLC grew its stake in HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after buying an additional 123 shares during the last quarter. Finally, Merit Financial Group LLC grew its stake in HealthEquity by 8.9% in the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock valued at $200,000 after buying an additional 172 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares in the company, valued at approximately $1,775,970. The trade was a 11.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares of the company’s stock, valued at $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock valued at $1,651,280 over the last quarter. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Barrington Research reissued an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a report on Friday, May 22nd. KeyCorp restated an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Citizens Jmp upped their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Royal Bank Of Canada lifted their price target on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $110.93.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $105.57 on Wednesday. The business has a fifty day moving average price of $94.03 and a two-hundred day moving average price of $86.10. The stock has a market capitalization of $8.83 billion, a PE ratio of 39.54, a P/E/G ratio of 1.80 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $107.62.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.